Anti-Human C5 Fc Silent Antibody, Clone Eculizumab (CAT#: CB-LX004-A) Datasheet

Product Type
Antibody
Description
Anti-Human C5-Fc silent antibody is derived from clone Eculizumab, which is a Human monoclonal antibody targeting the C5. And it is intended for the research of Autoimmune diseases.
Research Area
Cell Biology, Immunology,
Antigen Distribution
Restricted expression toward thyroid (RPKM 13.7).
Disease
Autoimmune diseases
Size
100 ug
Immunogen
Recombinant Human C5 protein
Species
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG4, Kappa
Clone Number
Eculizumab
Conjugation
Unconjugated
Source
Recombinant
Buffer
PBS, pH 7.4
Application
Funcs, In vivo assay
Application Notes
The use of diluent depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution.
Handling Advice
This product is for research use only. It is not intended for use in therapeutic or diagnostic procedures for humans or animals.
Storage Instructions
Product should be stored at -80°C. Repeated freeze and thaw cycles will cause loss of activity. Use product within 24 hours after thawing and keep on ice. Remainder amounts should be aliquoted and immediately re-freezed for future use. Aliquots should never be thawed more than once. Under recommended storage conditions, product is stable for at least one year.
Target
C5
Official Name
Complement C5
Full Name
Complement C5
Background
This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
Alternative Names
Complement C5; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; C5a anaphylatoxin; anaphylatoxin C5a analog; Complement component 5; Prepro-C5; C5Da; C5b; CPAMD4; ECLZB; C5
Gene ID
Uniprot ID

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK